Pharmaceuticals

Global Pharmaceuticals Native Starch Market Size and Forecast to 2029: Revenue, Growth, and Trends

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceuticals native starch market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Pharmaceuticals Native Starch Market Size Today And What Will Its Value Be At The End Of 2029?

The pharmaceuticals native starch market size has experienced significant expansion over recent years. It is anticipated to grow from $5.65 billion in 2024 to $6.11 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.1%. The historical increase can be attributed to several factors, including an elevated demand for natural excipients, increasing pharmaceutical output, a growing inclination towards biocompatible ingredients, the broadening of generic drug manufacturing, and rising regulatory endorsement for natural ingredients.

The pharmaceuticals native starch market is projected to experience substantial expansion over the next few years, with its size anticipated to reach $8.5 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.6%. This projected growth during the forecast period stems from factors such as increasing investment in pharmaceutical innovation, a heightened emphasis on sustainable sourcing, the broadening of applications in novel drug formulations, a rising demand for clean-label pharmaceutical products, and increasing healthcare expenditure in emerging markets. Furthermore, significant trends foreseen in this period include technological advancements in starch processing, innovations in drug delivery systems, the development of bio-based pharmaceutical ingredients, intensified research and development concerning plant-based excipients, and the creation of solubility and stability solutions.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

Which Key Drivers Are Powering Growth In The Pharmaceuticals Native Starch Market?

The escalating occurrence of chronic illnesses is anticipated to fuel the expansion of the pharmaceuticals native starch market. Chronic diseases are defined as prolonged medical conditions that typically advance gradually and persist for at least a year. This rise in chronic disease prevalence is primarily due to an aging global population, as older individuals are more susceptible to long-term health issues such as diabetes, cardiovascular diseases, arthritis, and cancer, which become more common with advancing age. Pharmaceuticals native starch proves beneficial in the context of chronic diseases by improving drug formulation stability, enhancing drug absorption, facilitating controlled drug release, supporting patient compliance, and ultimately bolstering the effectiveness and sustained management of these medical conditions. As an illustration, in June 2024, data from the Australian Institute of Health and Welfare indicated an increase in the death rate from chronic conditions, rising from 459 per 100,000 people in 2021 to 490 per 100,000 people in 2022. Therefore, the growing burden of chronic diseases is a significant driver for the growth of the pharmaceuticals native starch market.

Which Segment Categories Are Driving Maximum Growth In The Pharmaceuticals Native Starch Market?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Modified Potato Starch, Native Potato Starch

2) By Corn Starch: Modified Corn Starch, Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

What Key Trends Are Driving Growth In The Pharmaceuticals Native Starch Market?

Major companies operating in the pharmaceuticals native starch market are concentrating on developing innovative products, such as plant-based textures, to optimize drug formulation and improve patient compliance. Plant-derived texture refers to physical properties derived from botanical ingredients, including thickness and gel strength, aiding pharmaceuticals in using native starch by enhancing tablet binding, disintegration, and mouthfeel for improved natural drug formulations. For instance, in February 2024, Ingredion Incorporated, a US-based food company, launched Novation Indulge 2940 starch, a clean-label texturizer designed to enhance texture and stability in dairy and alternative dairy products. This novel pharmaceutical native starch offers functional properties that improve drug formulation performance, bioavailability, and controlled release, while also supporting the development of clean-label, sustainable products. Furthermore, NOVATION Indulge 2940 starch is a versatile ingredient that enhances texture, stability, and consumer acceptance in both dairy and alternative dairy products, by using clean-label, natural ingredients.

Who Are The Leading Companies Driving The Pharmaceuticals Native Starch Market?

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Tereos SCA, Roquette Frères SA., AGRANA, Tate & Lyle Public Limited Company, Colorcon Inc., Grain Processing Corporation, Siam Modified Starch Co. Ltd., BENEO GmbH, Gulshan Polyols Ltd., SPAC Starch Products (India) Private Limited, Universal Starch-Chem Allied Ltd., Sanstar Biopolymers Ltd., Emsland Group, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Shandong Liujia Pharmaceutical Excipient Co.Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

Which Region Holds The Largest Share In The Pharmaceuticals Native Starch Market Today?

North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp

Browse Through More Reports Similar to the Global Pharmaceuticals Native Starch Market 2025, By The Business Research Company

Generic Pharmaceuticals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

Pharmaceuticals Market 2025

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Radiopharmaceutical Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795